IBEX (NASDAQ:IBEX) Insider Julie Casteel Sells 11,677 Shares of Stock

IBEX Limited (NASDAQ:IBEX) insider Julie Casteel sold 11,677 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $50.72, for a total value of $592,257.44. Following the completion of the sale, the insider owned 100,594 shares in the company, valued at $5,102,127.68. The trade was a 10.40% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

IBEX Stock Up 3.9%

NASDAQ:IBEX opened at $52.23 on Wednesday. The company has a market cap of $696.23 million, a P/E ratio of 15.83 and a beta of 0.74. IBEX Limited has a twelve month low of $25.94 and a twelve month high of $52.29. The business has a 50 day moving average price of $43.52 and a two-hundred day moving average price of $34.63.

IBEX (NASDAQ:IBEX) last posted its quarterly earnings data on Thursday, November 5th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.20. The company had revenue of $175.23 million for the quarter, compared to the consensus estimate of $169.31 million. IBEX had a net margin of 7.34% and a return on equity of 29.10%.

Analysts Set New Price Targets

Several brokerages have issued reports on IBEX. Wall Street Zen upgraded shares of IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Robert W. Baird increased their price objective on shares of IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Monday, September 28th. Royal Bank Of Canada raised their price objective on IBEX from $40.00 to $45.00 and gave the company a “sector perform” rating in a report on Tuesday. Finally, Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, IBEX has an average rating of “Hold” and an average price target of $44.50.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Bullock Wealth Management Group acquired a new stake in shares of IBEX in the 3rd quarter valued at approximately $36,000. Signaturefd LLC grew its stake in shares of IBEX by 272.4% in the third quarter. Signaturefd LLC now owns 1,784 shares of the company’s stock valued at $77,000 after buying an additional 1,305 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of IBEX in the third quarter valued at $85,000. D Orazio & Associates Inc. acquired a new position in IBEX during the third quarter worth $213,000. Finally, Vise Technologies Inc. acquired a new position in IBEX during the third quarter worth $223,000. Institutional investors and hedge funds own 81.24% of the company’s stock.

Key Stories Impacting IBEX

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
• Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
• Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
• Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing

About IBEX

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.